NCT00386113 Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Status COMPLETED Phase PHASE2
NCT00385840 Study to Evaluate the Immunogenicity and Safety of a Second Vaccination With the Adjuvanted Influenza Vaccine Candidate Status COMPLETED Phase PHASE2
NCT00383539 Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults Status COMPLETED Phase PHASE3
NCT00383526 Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly Status COMPLETED Phase PHASE3
NCT00383123 Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children Status COMPLETED Phase PHASE3
NCT00382980 Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults Status COMPLETED Phase PHASE1
NCT00382187 Safety and Immunogenicity of Two Adjuvanted and One Non-adjuvanted H5N1 Influenza Vaccine in Adults Status COMPLETED Phase PHASE2
NCT00380237 Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B) Status COMPLETED Phase PHASE1
NCT00380211 Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults Status COMPLETED Phase PHASE3
NCT00377611 Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™ Status COMPLETED Phase PHASE4
NCT00377585 Demonstrate the Superiority of the Immune Response of Adjuvanted Influenza Vaccine Induced in an Adult Population Status COMPLETED Phase PHASE2
NCT00376402 Study of a Pandemic Influenza Vaccine in Elderly Participants Status COMPLETED Phase PHASE2
NCT00375206 A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine Status COMPLETED Phase PHASE1
NCT00374842 Study to Evaluate the Immunogenicity and Safety of 2 Formulations of GlaxoSmithKline (GSK) Biologicals' GSK1247446A Low Dose Influenza Vaccine Candidate Status COMPLETED Phase PHASE2
NCT00372255 Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years Status COMPLETED Phase PHASE4
NCT00363870 A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults Status COMPLETED Phase PHASE4